Report post

Who owns BioAtla Inc?

Its CAB portfolio include MABs & ADCS, BA3011, and BA3021. The company was founded by Jay M. Short and Carolyn Anderson in March 2007 and is headquartered in San Diego, CA. BCAB | Complete BioAtla Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Is BioAtla a good stock to buy?

The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings. According to analysts' consensus price target of $14.80, BioAtla has a forecasted upside of 640.0% from its current price of $2.00. BioAtla has only been the subject of 2 research reports in the past 90 days.

Should you buy BioAtla (BCAB) stock?

There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" BCAB shares. View BCAB analyst ratings or view top-rated stocks. What is BioAtla's stock price target for 2024? 5 equities research analysts have issued 12 month target prices for BioAtla's shares.

The World's Leading Crypto Trading Platform

Get my welcome gifts